Challenge: A way to understand and instruct on best practices for delivering and accepting HIV drug treatments in Africa.
therapy. Some studies indicate that suboptimal adherence to antiretroviral therapy (ART) might be caused, in part, by a poor relationship between patient and health-care provider, and it was suggested to explore ways to improve this relationship.
The group initially consisted of seven Master's degree students at KU Leuven -University of Leuven Mieke Vandamme.
Methods:
The development of the methodology is described in a separate abstract (this issue). Transdisciplinary research tools, such as an Actor Constellation and a Three Types of Knowledge exercise (www.transdisciplinarity.ch/toolbox), were leveraged to encourage transdisciplinary thinking within the initial group, and to identify missing experts and stakeholders. As a result, the initial group sought support among non-governmental organizations (NGOs) and reached out to experts on the subject, in order to form a transdisciplithe following experts and stakeholders, in addition to the initial group. Biomedical support came from Dr. Jordan, Dr. Mosha, Dr Sangeda and Dr De Oliveira. NGO support came from Mrs Baert, Mr. Bernard and Mr. Thompson, who each work for a different NGO familiar with the topic. Support in the organization came from Mrs. Kiekens and Mr. Nova Blanco.
Results:
The initial group began with fact-checking the assumptions stated in the challenge description and reformulated the challenge to include their insights into the assumptions based on literature searches (Suppl. 2). The purpose of the re-formulation was to clarify the goal of the challenge. The assumptions were found to be valid, and it was decided to follow the suggestion of the challenge submitter and focus on the patient-provider relationship. Following the transdisciplinary exercises, additional actors were added to the team, and knowledge was gathered. Most knowledge on the current situation was obtained through video conference calls with local experts and information sourced from the World Health Organization (WHO) and government agencies, in addition to reviewing the literature. However, after gathering knowledge from the supporting team and different sources, it was decided that intervention in the patient-provider relationship was not the best next step to increase adherence to antiretroviral drugs (ARVs) because the burden on local doctors was already very high and would only increase in the coming years. A better relationship with the patient would be an extra burden on the time of health personnel.
Instead, the team researched the feasibility of implementing peer support groups in Dar Es Salaam, Tanzania, as a possible way to increase patient adherence. This would circumvent the time constraints on doctors and take cues from other regions where these groups showed promising results. A questionnaire targeting HIV patients in Dar Es Salaam was created with the experts with the purpose of gaining practical knowledge on the perceived value and acceptability of peer support groups in Dar Es Salaam (Suppl. 3 and 4). The supporting team suggested a similar questionnaire also for the doctors treating these HIV patients (Suppl. 5). Answers to these questionnaires are currently being collected under ethical clearance number NIMR/ HQ/R.8a/Vol.IX/2228.
To visualize the steps taken to achieve the goal and to publish the output of this project, the team created infographics and started a blog, serving as a guide for future transdisciplinary teams. The transdisciplinary procedure, illustrated with these infographics, was written down as a separate abstract (Dehens et al, this issue). The "
" approach was applied to the project retrospectively (suppl 6). This can be used as a guidance tool for further transdisciplinary research around this challenge.
Conclusion:
With the creation of the questionnaire, a acceptability of peer support groups in combating problems with adherence in regions where time constraints on skilled health workers limit possible interventions. The results of the questionnaire will suggest the desirability and feasibility of setting up peer support groups. As this team was a pilot group, a new team will continue this challenge in the next academic year to build on the insights described here. We suggest that they use the blog to update the progress of the project. Researcher NAME OF THE CHALLENGE
DRUG TREATMENTS IN AFRICA
If you have more than one challenge, please submit each challenge separately. Please be aware that if the same or a very similar challenge is submitted by multiple actors, we will pool this into a single challenge, and as a result, the challenge might diverge slightly from what you submitted.
As of 2016, 18 million people are receiving antiretroviral therapy (ART) for the treatment of HIV infection. Some level of HIV drug resistance (HIVDR) is inevitable and expected to emerge and be transmitted in populations infected with HIV and receiving ART. However, recent data suggest an increase in levels of HIVDR to a point that there may be increased mortality and or morbidity. Levels of HIVDR in Africa, the continent most heavily affected by HIV, may be In WHO's 2016 global based on data from 59 countries from more than 12 000 clinics from cohorts of patients receiving ART between 2004 and 2014, high levels of appropriate antiretroviral (ARV) drug prescribing were observed, with over 99% of people prescribed regimens according to national or international HIV treatment guidelines. Global levels of loss to follow-up (LTFU) (unknown outcome) at 12 months during the same period averaged 20%, exceeding the WHO-recommended target of 15%.
to 24.5% in 2012 11.9% in 2004 to 24.5% in 2012 (p<0.001). Globally, retention on ART at 12 months averaged only 73.5% amongst clinics reporting data, falling short of the WHO-recommended target of 85% or above. Estimates of retention varied considerably across regions. Adherence, as estimated by on-time pill pick-up and on-time appointment keeping, fell below global targets. On-time pill pick-up was a strong predictor of clinic-level viral load suppression (p<0.001) suggesting that identifying clinics with less-than-desirable pill pick-up, then targeting their patient populations for adherence interventions, may lead to improvements in overall population-level outcomes. Amongst 1150 clinics monitoring drug stock outs, 35.7% had at least one drug stock out of routinely dispensed ARV drugs during their respective reporting year, thus failing to attain the WHO-recommended target of no ARV drug stock outs.
WHO worries that no matter how good the drugs may be, the infrastructure built over the last decade will be pushed even further when more people are initiated on ART in the face of dwindling resources. Moreover, increasing HIVDR in Africa may jeopardize HIV treatment in other parts of the world.
Strong doctor-patient or health care provider-patient relationships are vital to sustaining millions of patients on ART in resource limited countries (RLS). However, some recent evidence suggests that interactions between health care providers and patients may be strengthened by making it more of a partnership and less paternalistic. For example, in Malawi, 14% of traced patients who had disengaged from care and stopped ART reported that they feared being scolded for having interrupted care if they returned to clinic. 5% felt they were better and did not need care, 9% had work obligations, 2% felt the medicine was not helpful, 9% had side effects (Ministry of Health Malawi/WHO unpublished data). Strengthening of the provider-patient relationship elimination of paternalistic behaviors on the part of health care providers may help to minimize these and other causes of disengagement from care.
For example, can you imagine how you want the reach?
The research group is asked to identify the best next steps to strengthen provider-patient relationships in ART clinics in Africa. The group will conduct case studies in Windhoek, Namibia and in Durban South Africa, with local people to characterize provider-patient relationships and identify ways to improve them. Through a series of case studies and conversations with patients, doctors, nurses, health care providers, general public and community members, the group should suggest steps that can be taken to improve the provider-patient relationship.
WHO has drafted a 2017-2021 action plan to reduce HIV drug resistance in developing countries, outlining a collective strategy, including surveillance activities, service delivery interventions, diagnostic strengthening, and enabling mechanisms. These cover several disciplines in various domains of science.
This action plan outlines the problems, the goals and the possible steps to take. However, this action plan is not local authorities and communities. The action plan describes local enabling mechanisms, but it would be interesting particular case study.
this challenge, you need to pick at least one of each domain. Such evidence of poor adherence to therapy as described above is indeed a notable factor associated with the emergence of drug-resistant HIV. Notably, resistant strains of HIV are selected for when the viral load stays above >50
Domain of Humanities and Social Sciences:

Arts
Strong health care provider-patient relationships are vital to sustaining millions of patients on ART in resource limited countries (RLS). Trust and a therapeutic relationship between patient and physician remain central in the ART initi-Supplement 2: The amended challenge document patients and their ability to maintain their health, especially when they were isolated from other sources of support in Malawi 14% of traced patients who had disengaged from care and stopped ART reported that they feared being scolded for having interrupted their care (Ministry of Health Malawi/WHO unpublished data).
that paternalistic behaviours obstruct clear communication between the patient and health care provider. This leads -tient-centred efforts may help to minimize some of the causes of disengagement from care. However, it is worth noting that sometimes paternalistic behaviours can be productive. For instance, paternalism could cause health care providers to omit offering patients the opportunity to decline the opt-out HIV test.
There is a wide range of documentation on how a functional and strong patient-provider relationship can improve -ship. There are no usable case-studies on how such methods have been put into practice and the results found from such initiatives. One trend that does seem apparent among policy researchers is to give practitioners more time with patients by cutting time spent on other duties. The South African organisation Right to Care is a good example of this policy. Their mobile app, the Medication Adherence App, is one way that reminders can be set for patients without secretarial staff having to spend time on this themselves. So these schemes create time for improving the patient-provider relationship, but are not directly related to the improvement of such relationships. The challenge is
The research group is asked to identify the best next steps to strengthen provider-patient relationships in ART clinics in Africa. The group will conduct case studies in Windhoek Namibia, Durban South Africa, Dar es Salaam Tanzania, with local people to characterize provider-patient relationships and identify ways to improve them. Through a series of case studies and conversations with patients, doctors, nurses, health care providers, general public and community members, the group should suggest steps that can be taken to improve the provider-patient relationship.
isations have created such case-studies, or even have reports on ways to improve the patient-provider relationship, especially in the context of HIV in Africa. One suggestion for the group project would be the organisation of such a -mental phase to test the methods in question. Another option would be to compile ways in which the patient-provider relationship could be improved. It may be that there is more on this in western countries, so the challenge would be -vider relationship. Either there are some available, which would require more search time and questioning policy researchers and such, or the project could create one and thus provide a useful resource for health practitioners.
WHO has drafted a 2017-2021 action plan to reduce HIV drug resistance in developing countries, outlining a collective strategy, including surveillance activities, service delivery interventions, diagnostic strengthening, and enabling mechanisms. These cover several disciplines in various domains of science. This action plan outlines the problems, -tions that can vary widely. Though the WHO action plan describes local enabling mechanisms, it would be interesting Supplement 3: Questionnaire for patients (Swahili) Msaili: Tarehe:
Maelekezo:
Umri wako ni upi?
Jinsia yako ni ipi?
Kiwango cha kipato chako ni kipi?
Je ni lini ulipima kwa mara ya kwanza kama na kugunduliwa kuwa na virusi vya ukimwi (VVU)? ____________ (mwaka) Wagonjwa wengi wanapata ugumu kumeza dawa zao, kwa sababu mbalimbali. Kama ulikosa kumeza dawa zako, sababu kubwa ilikuwa ipi? Unaweza kujaza kisanduku zaidi ya kimoja.
Yapi kati ya haya yafuatayo yangeweza kukusaidia kuhakikisha unameza vidonge vyako bila kukosa? Unaweza ukachagua zaidi ya kisanduku kimoja.
Sehemu nyingine duniani 'wagonjwa wataalam' waliosomeshwa na wanatauluma wa afya, wanatoa msaada kwa wenzao wagonjwa. Hawa huongoza "makundi ya kusaidiana", hivyo kusaidiana katika maisha yao. Je unaona kuwa hili ni wazo zuri?
Kwanini (sababu):
Msaada wa aina gani ungependa (watalaam) hawa wagonjwa wakupatie? pamoja nilivyoelekezwa wengine kuhusu ugonjwa wangu Kuwa 'mgonjwa mtaalam' mtu mwenye VVU atapatiwa mafunzo na wataalam wa afya katika mafunzi mafupi. Baadae kwa haiari yao watatumia elimu yao kuwasaidia na kuwaelimisha wagonjwa wenzao. Baadhi ya kazi ni kama kuwa kiongozi wa kundi, kukusanya taarifa, kugawa dawa kwa wagonjwa wengine, kuwa msomeshaji n.k. Je ungependa kuwa 'mgonjwa mtaalam'?
Je ungependa kuudhuria mikutano ya kikundi cha wagonjwa kusaidiana mara kwa mara, inayoongozwa na 'mgonjwa mtaalam'? Mara ngapi ungekuwa radhi kuhudhuria mikutano ya vikundi vya wagonjwa kusaidiana ?
Je hoja yako kubwa ingekuwa nini kuhusiana na kundi la kusaidiana? ………………………………………………………………………………………………………………………………… Je kwa ujumla unachukua mda gani kupata dawa zako? (jumuisha muda wa kutoka nyumbani mpaka utakaporudi tena nyumbani).
Unatathmini vipi muda unaotumia kupata dawa zako ? ( Zungushia kwenye skeli)
Je ugekubali kujiunga kliniki kwako na kundi la la wagonjwa la kusaidiana? Mahali ambapo kundi hili hukutana ili usiende mara kwa mara katika hospitali?
Je unaonaje kama ungekuwa unaonana na daktari wako mara chache zaidi? Unadhani kumuona daktari ingekuwa muhimu: Supplement Which of the following help would make you take your pills properly? You can tick more than one box.
In some regions 'expert patients', who have received training from health professionals, are supporting and educating their fellow patients. They lead and organize peer support groups, which support patients through their lives. Do you think this is a good idea? Supplement 4: Questionnaire for patients (English) Why:
What help from a fellow (or expert) patient do you feel is appropriate to support you?
To become an 'expert patient' a person with HIV will receive training by healthcare professionals in a short training program. Then they will voluntarily use their knowledge to support and educate fellow patients. Tasks could include being group leader, gathering information, distributing medication to other patients, becoming an educator etc.) Would you be interested in becoming such an expert patient?
Would you like to attend regular peer support sessions that are led by an expert patient?
How often would you be willing to attend peer support sessions?
…………………………………………………………………………………………………………………………………
DRUG DELIVERY
How much time does it take in total to get your medication? (Including the time from leaving home until you return back home).
How do you feel about how long it takes to pick up your medication? (draw a cross on the scale)
Would you consider joining a local peer support group, where you would receive your medication, so that you don't have to pick up your medicines at the hospital so often? Which of the following help do you think could make the patient take their pills properly? You can tick more than one box.
In some regions 'expert patients', who have received training from health professionals, are supporting and educating their fellow patients. They lead and organize peer support groups, which support patients through their lives. Do you think this is a good idea?
Why:
What help from a fellow (or expert) patient do you feel is appropriate to support your patient?
To become an 'expert patient' a person with HIV will receive training by healthcare professionals in a short training program. Then they will voluntarily use their knowledge to support and educate fellow patients. Tasks could include being group leader, gathering information, distributing medication to other patients, becoming an educator etc.) Do you think some patients would be interested in becoming such an expert patient?
Would you be willing to advice and educate the expert patients?
If yes, how often would you be willing to advice expert patients?
DRUG DELIVERY
How much time does it take in total for a patient to get his medication from the clinic? (from leaving home until returning back home).
How do you think patient feel about how long it takes to pick up their medication? (draw a cross on the scale) Do you think patients would consider joining a local peer support group, where they would receive their medication, so that they don't have to pick up their medicines at the hospital so often?
How often do you think a doctor's visit is necessary?
Would you think your patients would be more or less likely to take their drugs if they didn't have to visit the hospital as often?
REFLECTIVE STEPS: AN EXERCISE
To improve the transdisciplinary research process, a 10-step approach has been proposed by C. Pohl (Pohl This approach is here applied to the transdisciplinary challenge "A way to understand and instruct on best practices for delivering and accepting HIV drug treatments in Africa". The different steps are studied and applied at the end of and constitutes an overview and systemization of the performed work. It can serve as a basis to improve the process during further work of future teams continuing on the same challenge.
article by C. Pohl and afterwards applied to the challenge and the performed work in blue text. The two realms are the realm of science (research, abstract thoughts and ideas) and the realm of practice (the real situations, practicalities). The actual challenge of TD-research is to provide a link between these realms and its goal Once the problem is accepted to be transdisciplinary, the challenge is addressed in a holistic manner. Researchers with different educational backgrounds see the problem through different frameworks. Mixing these differences thought styles will produce a necessary transdisciplinary approach. (Figure 1) 
Applied to our challenge
The actual research question: a way to understand and instruct on best practices for delivering and accepting HIV drug treatments in Africa: improvement of the patient-provider relationship. This research question is transdisciplinary. Taking into account the reality of practices and experiences in problem, complex interactions in the practical situation need to be webbed and transformed to improve the situation.
-
Applied to our challenge
The challenge is situated in the larger context of preventing the spreading of HIVDR. Through the following path the research will be societally relevant: Better patient-provider relations improve the adherence of ART patients which is one of the ways of HIVDR prevention. Through assessing the assumptions made in the challenge proposal also clear boundaries are set up to outline the scope of the challenge to study.
The patient provider relationship is differently set-up in each different hospital community. The research treats different hospital communities (the patients on ART in a hospital) as a target group and as the basis for the research. Therefore, every different hospital community represents a case study where a policy can be developed and rolled out. Note that even within each hospital community there are circumferential factors THE FOUR MOST GENERAL STAGES IN THE POLICY CYCLE ARE (Figure 2 ): 1. Problem framing, when society becomes aware of a problem and disputes what the problem is about and for whom it is a problem at all.
The main problem that will be tackled is that doctors simply don't have enough time to develop a doctorpatient relationship. Therefore the patient misses "psychological care and investment" which will motivate him and comfort him in his ART therapy adherence. 
The goal is twofold: 1. Shift tasks away from the doctors, so they have more time to focus on what is more important. 2. Improve the care especially in a more social way.
3. Policy implementation, when society discusses the policies or measures to be taken, and implements them
Different approaches can be used to overcome the gap of care and investment: Mix skilled local health teams to increase capacity to deliver services: Setting up peer patient support groups Training expert patients which will take care of basic tasks Community participation:
Engage communities and people living with HIV to deliver essential basic care.
4. Policy evaluation, when discussions start about how far the implemented policies help to handle the problem
An important question here is how to measure the impact in order to evaluate the implementation of the changes. The ART adherence is the main parameter to monitor since that is what eventually needs to improve. Monialways contact the different actors involved in the problem. They are a valuable source of practicalities and ideas to further improve the situation. 
Where do we want to go to. What would be the ideal situation. Everyone is happily following their ART therapy.
Knowledge about how we come from where we are to where we should be (transformation knowledge)
How will we improve the situation. How can we apply the new policy? Are there any regulations we need to follow? How to implement our policies in a practical way?
Good congruence between the knowledge the research provides and the knowledge demand (and expectations) of target groups is essential! CONNECTION WITH POLICY FRAMING The disciplines in bold are the disciplines present in the team. Of course prioritization of the disciplines as well as actors to be involved with is necessary.
A total of six to ten is a workable number of disciplines and societal actors.
CONSULTING, CO-PRODUCING).
Applied to our challenge To inform
The WHO spokesperson requesting the challenge is informed of the progress made.
To consult
Other research groups are requested for expert opinions. By using a questionnaire the patients and doctors are reached to solicit their opinion. NGOs are contacted to gather information about current practices.
Within the research group, different point of views are discussed. are contacted to inform the research group about the local situation and to help writing the questionnaire.
ACTOR CONSTELLATION: MODERATED ROLE-PLAY PLACING SOCIETAL ACTORS AND DISCI-
It leads to:
Rethinking actor placing Detection missing societal actors or disciplines.
Arguing about who is more important for the research -volved in the research.
Applied to our challenge
with respect to solving the research question. (Figure 3) No real roleplay has been performed during the orientation of the research. However an important discussion about the relative importance of the different actors with respect to the research question has taken place. This resulted in the idea that the importance of the different actors changes depending on the stage the research is in. Because the research stage you are in determines the mindset in which you look at the research question. For example: during the policy implementation, cooperation with hospital/doctors/nurses, patients, NGO, government will be the most important. When researching different possible solutions, cooperation with think tanks and other HIV research groups is necessary. To acquire systems knowledge the hospital community and patients are the main actors to be involved with and to study.
CLARIFY EXPECTATIONS AND INTERESTS OF THE SOCIETAL ACTORS AND DISCIPLINES INVOLVED.
Essential Questions are: Who initiates the interaction? Who participates? Why participation? Regarding which issues and when? By which method(s)? Figure 3 . Output of the actor constellation workshop on this challenge
